Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,650,000
-
Number of holders
-
309
-
Total 13F shares, excl. options
-
129,727,357
-
Shares change
-
-2,036,817
-
Total reported value, excl. options
-
$5,890,257,760
-
Value change
-
-$85,620,767
-
Put/Call ratio
-
96.42%
-
Number of buys
-
147
-
Number of sells
-
-150
-
Price
-
$45.41
Significant Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2021
370 filings reported holding HALO - HALOZYME THERAPEUTICS, INC. - Common Stock as of Q2 2021.
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) has 309 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 129,727,357 shares
.
Largest 10 shareholders include BlackRock Inc. (19,066,438 shares), VANGUARD GROUP INC (13,638,304 shares), Artisan Partners Limited Partnership (10,189,688 shares), Invesco Ltd. (5,651,622 shares), JPMORGAN CHASE & CO (5,255,208 shares), STATE STREET CORP (5,161,793 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (4,882,486 shares), SNYDER CAPITAL MANAGEMENT L P (3,176,404 shares), MACQUARIE GROUP LTD (2,941,938 shares), and GEODE CAPITAL MANAGEMENT, LLC (2,446,622 shares).
This table shows the top 309 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.